We have located links that may give you full text access.
Effects of mature cystic teratoma on reproductive health and malignant transformation: A retrospective analysis of 80 cases.
OBJECTIVE: Examining the cases of mature cystic teratoma (MCT) that are diagnosed and treated in our clinic regarding their association with fertility; and detecting the rate of malignant degeneration and the types of malignancies.
MATERIAL AND METHODS: Patients, operated due to adnexal mass between April 2012 and August 2017 and diagnosed with MCT, were retrospectively examined. Mean age of the 80 cases, which met the criteria, was 30.60±10.5. 9 were suffering from infertility, according to hospital records. 67% of these (6 cases) were accompanied by endometriosis and MCT was bilateral in 55.5% of them (5 cases). Malignant degeneration was present in 6.25% of the cases (5 cases), all were monodermal tumors. Malignant degeneration was more common among the cases with adnexal masses larger in diameter (9.1±2.9 cm) and with postmenopausal age. Tumor markers were in normal range for the patients that developed malignancy. Malignant degeneration was not present among the infertile patients with endometriosis.
RESULTS: Although MCTs do not seem to affect the ovarian reserve negatively, the complaint of infertility is prominent in case of concurrent presence of endometriosis. During assessment, concurrent endometriosis should be considered. Imaging findings, large adnexal masses and postmenopausal period are important for the assessment of MCT concerning malignant degeneration. It should not be overlooked: tumor markers may be normal.
CONCLUSION: MCTs can be present concurrent with endometriomas. In such cases the complaints of infertility are more distinct. In MCT malign degeneration, mass diameter, complex mass internal structure and postmenopausal status are important factors.
MATERIAL AND METHODS: Patients, operated due to adnexal mass between April 2012 and August 2017 and diagnosed with MCT, were retrospectively examined. Mean age of the 80 cases, which met the criteria, was 30.60±10.5. 9 were suffering from infertility, according to hospital records. 67% of these (6 cases) were accompanied by endometriosis and MCT was bilateral in 55.5% of them (5 cases). Malignant degeneration was present in 6.25% of the cases (5 cases), all were monodermal tumors. Malignant degeneration was more common among the cases with adnexal masses larger in diameter (9.1±2.9 cm) and with postmenopausal age. Tumor markers were in normal range for the patients that developed malignancy. Malignant degeneration was not present among the infertile patients with endometriosis.
RESULTS: Although MCTs do not seem to affect the ovarian reserve negatively, the complaint of infertility is prominent in case of concurrent presence of endometriosis. During assessment, concurrent endometriosis should be considered. Imaging findings, large adnexal masses and postmenopausal period are important for the assessment of MCT concerning malignant degeneration. It should not be overlooked: tumor markers may be normal.
CONCLUSION: MCTs can be present concurrent with endometriomas. In such cases the complaints of infertility are more distinct. In MCT malign degeneration, mass diameter, complex mass internal structure and postmenopausal status are important factors.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app